Trial intelligence / Profile preview

Circumcision bleeding under ketamine + midazolam versus propofol + fentanyl + lidocaine anesthesia

ACTRN12616000189426Phase 4Completed

Sponsor
Derya Karasu
Start
Oct 2014
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ketamine, midazolam, propofol, fentanyl and lidocaine in postoperative hemorrhage (2 arms), sponsored by Derya Karasu. Primary endpoint: Intraoperative surgical site bleeding. Started Oct 2014; status: completed.

02

Drugs

ketaminemidazolampropofolfentanyllidocaine
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on ACTRN12616000189426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616000189426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call